This position will be in the Division of Hematology in the Department of Medicine at the University of North Carolina at Chapel Hill. The individual in this position will be expected to manage patients with leukemia specifically chronic lymphocytic leukemia. They will also be expected to manage individuals with monoclonal B cell lymphocytosis and occasionally low-grade lymphomas. This individual will have a robust clinical research program, which would include investigator initiated clinical trials, clinical trials working with pharmaceutical company partners and cooperative group trials. Additionally, this individual could have a robust translational oncology program that focused on a better understanding of the biology of chronic lymphocytic leukemia or MBCL or biomarkers of disease severity for those diseases.
Education and Experience:
The preferred individual will have at least three years of experience managing patients with CLL, MBL, or small cell lymphoma and a history of leading clinical research studies for this patient population. They will have a history of working collaboratively in an academic medical setting and mentoring hematology/oncology trainees.
Carolina rates among the nation’s great institutions of higher education, set on an historic and beautiful campus that celebrates all four seasons. Carolina’s students, faculty and staff come here from around the world, bringing varied cultural, racial and ethnic heritages that help make UNC-Chapel Hill a thriving intellectual center. We’re repeatedly ranked the nation’s best value in higher education for students seeking to earn a college degree – the University has garnered the top spot each time since the ranking’s launch in 1998.Whether you’ve just started your career, are new to academia or are a seasoned professional with assorted campus experiences to draw on, we hope you will find a great place at Carolina.